Curigliano G, Mueller V, Borges V, Hamilton E, et al. Tucatinib vs Placebo Added to Trastuzumab and Capecitabine for Patients with Pretreated HER2+ Metastatic Breast Cancer with and without Brain Metastases (HER2CLIMB): Final Overall Survival Analysis. Ann Oncol 2021 Dec 22. pii: S0923-7534(21)04879.
PMID: 34954044